carbenoxolone sodium has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, B; Wang, H; Xu, H; Zhang, Y | 1 |
| Asai, M; Hashimoto, K; Iwasaki, Y; Kambayashi, M; Nigawara, T; Sashinami, H; Suda, T; Yoshida, M | 1 |
2 other study(ies) available for carbenoxolone sodium and Pituitary Neoplasms
| Article | Year |
|---|---|
Effects of inhibiting connexin43 on expression of fibroblast growth factor in prolactinomas in rats.
Topics: Analysis of Variance; Animals; Carbenoxolone; Connexin 43; Disease Models, Animal; Estradiol; Fibroblast Growth Factors; Gene Expression Regulation, Neoplastic; Organ Size; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Rats | 2016 |
Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adenoma; Adrenocorticotropic Hormone; Animals; Apoptosis; Carbenoxolone; Cell Line, Tumor; Feedback, Physiological; Glucocorticoids; Hydrocortisone; Mice; Pituitary ACTH Hypersecretion; Pituitary Neoplasms | 2006 |